Pioneering RNA Cell Therapy for Autoimmune Diseases

Time: 11:00 am
day: Conference Day Two


  • Developing the first RNA cell therapy in an autoimmune disease, Descartes-08
  • Sharing long-term follow-up data from the phase 1/2a open-label trial in patients with myasthenia gravis
  • Discussing the next steps for Descartes-08 in myasthenia gravis and other autoimmune indications